These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 6200661)

  • 1. [Role of immunologic analysis of bronchoalveolar lavage fluid in the study of interstitial pulmonary fibrosis (review of the literature)].
    Belokrinitskiĭ DV; Kudriavitskiĭ AI; Kornev BM
    Lab Delo; 1984; (2):67-75. PubMed ID: 6200661
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bronchoalveolar immunoglobulins in sarcoidosis].
    Bauer W; Gorny MK; Morell A; Baumann HR
    Schweiz Med Wochenschr; 1985 Jan; 115(3):103-5. PubMed ID: 3871964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of activated lymphocytes in bronchoalveolar lavage fluid (BALF) from patients with various diffuse interstitial lung diseases].
    Fujimura N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Jul; 22(7):552-61. PubMed ID: 6334190
    [No Abstract]   [Full Text] [Related]  

  • 4. [T-lymphocyte subpopulations in bronchoalveolar lavage in pulmonary sarcoidosis and other interstitial pulmonary diseases].
    Petrek M; Kolek V
    Cas Lek Cesk; 1993 Jun; 132(12):365-8. PubMed ID: 8343944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased bronchoalveolar IgG-secreting cells in interstitial lung diseases.
    Lawrence EC; Martin RR; Blaese RM; Teague RB; Awe RJ; Wilson RK; Deaton WJ; Bloom K; Greenberg SD; Stevens PM
    N Engl J Med; 1980 May; 302(21):1186-8. PubMed ID: 7366658
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes.
    Hunninghake GW; Crystal RG
    J Clin Invest; 1981 Jan; 67(1):86-92. PubMed ID: 6969734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cell count and immunoglobulin level in the bronchoalveolar lavage fluid (BALF) in patients with sarcoidosis].
    Oklek K; Ziora D; Niepsuj G; Jastrzebski D
    Pneumonol Pol; 1990 Jan; 58(1):17-25. PubMed ID: 2326224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenetic mechanisms in immunologic lung disease.
    Reynolds HY
    Hosp Pract (Off Ed); 1986 Apr; 21(4):91-9, 103-8. PubMed ID: 2937797
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunoglobulin content in bronchoalveolar lavage fluid in sarcoidosis].
    Ferner S; Bigl H; Ballin A; Leonhardt P
    Z Erkr Atmungsorgane; 1988; 170(2):118-26. PubMed ID: 3400285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid interstitial pneumonia: findings at bronchoalveolar lavage.
    Ishizaki T; Miyabo S; Koshino T; Fujimura M; Ueda M; Sato H; Kitagawa M
    Eur J Respir Dis; 1985 Aug; 67(2):128-32. PubMed ID: 3876947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Air-space immunoglobulin production and levels in bronchoalveolar lavage fluid of normal subjects and patients with sarcoidosis.
    Rankin JA; Naegel GP; Schrader CE; Matthay RA; Reynolds HY
    Am Rev Respir Dis; 1983 Apr; 127(4):442-8. PubMed ID: 6682299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic concepts relating to the pathogenesis of diffuse interstitial lung diseases (emphasizing granulomatous forms and idiopathic pulmonary fibrosis).
    Reynolds HY
    Trans Am Clin Climatol Assoc; 1980; 91():16-31. PubMed ID: 552178
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oxygen radical production by alveolar macrophages in sarcoidosis in relation to activity status of bronchoalveolar lavage lymphocytes].
    Strausz J; Müller-Quernheim J; Steppling H; Nagel M; Ferlinz R
    Pneumologie; 1990 Feb; 44 Suppl 1():222-3. PubMed ID: 2367371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of the pathogenesis of fibrosing alveolitis and sarcoidosis].
    Pokhodzeĭ IV; Ses' TP
    Ter Arkh; 1988; 60(10):129-32. PubMed ID: 3065956
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interleukin 1 secretion from alveolar macrophages in pulmonary sarcoidosis].
    Barth J; Kreipe H; Radzun HJ; Petermann W
    Pneumologie; 1990 Feb; 44 Suppl 1():215-6. PubMed ID: 2367368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interstitial lung diseases. I. Pathomorphological and immunological aspects and the methods of studies].
    Hajduk B; Małecka G; Derentowicz P; Roszkowski W
    Pneumonol Pol; 1990; 58(4-5):263-8. PubMed ID: 2144046
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bronchoalveolar lavage in patients with sarcoidosis--methodologic aspects of the collection, immunologic characterization of lymphocytes and studies of immunoglobulin content].
    Ballin A; Bigl H; Ferner S; Fiebig H; Leonhardt P; Neubert R; Cebulla M
    Z Erkr Atmungsorgane; 1988; 170(2):108-17. PubMed ID: 2969649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic lung disease (part 2).
    Reynolds HY
    Chest; 1982 Jun; 81(6):745-51. PubMed ID: 6978800
    [No Abstract]   [Full Text] [Related]  

  • 19. [Status of systemic and local immunity in patients with sarcoidosis].
    Chernushenko EF; Goncharova SI; Belianovskaia TI
    Klin Med (Mosk); 1986 Dec; 64(12):40-4. PubMed ID: 3494158
    [No Abstract]   [Full Text] [Related]  

  • 20. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.
    Hunninghake GW
    Am Rev Respir Dis; 1984 Apr; 129(4):569-72. PubMed ID: 6608889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.